Suning.com's financial health is alarming with significant liabilities, negative EBIT, and declining revenue. Its low liquid assets and recent loss of CN¥14b make it a risky investment. A turnaround, though possible, seems unlikely given the current financial situation.
The consistent decrease in Suning.com's share price and its declining revenues gives cause for concern for potential investors. It's suggested that clear signs of company growth would be necessary before predicting a stabilization in the share price.
Suning.com Co.,LTD. Stock Forum
$Alibaba (BABA.US)$
$BABA-W (09988.HK)$
$TENCENT (00700.HK)$
$Suning.com Co.,LTD. (002024.SZ)$
$Suning.com Co.,LTD. (002024.SZ)$
$Suning.com Co.,LTD. (002024.SZ)$
$Alibaba (BABA.US)$
$Alibaba Group Holding (05843.HK)$
$XIAOMI-W (01810.HK)$
$Suning.com Co.,LTD. (002024.SZ)$
$Alibaba (BABA.US)$
$BABA-W (09988.HK)$
$Qingdao Haier Biomedical Co., Ltd. (688139.SH)$
$XIAOMI-W (01810.HK)$
$Suning.com Co.,LTD. (002024.SZ)$
$BABA-W (09988.HK)$
$Alibaba (BABA.US)$
$XIAOMI-W (01810.HK)$
$Midea Group Co., Ltd (000333.SZ)$
$Qingdao Haier Biomedical Co., Ltd. (688139.SH)$
$Alibaba (BABA.US)$
$BABA N2411 (05844.HK)$
$Suning.com Co.,LTD. (002024.SZ)$
No comment yet